Crawford Fund Management, LLC Exact Sciences Corp Transaction History
Crawford Fund Management, LLC
- $396 Billion
- Q2 2024
A detailed history of Crawford Fund Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Crawford Fund Management, LLC holds 20,000 shares of EXAS stock, worth $1.06 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$1.06 Million% of portfolio
0.21%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
651Shares Held
166MCall Options Held
1.96MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA18.2MShares$967 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$878 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$787 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$642 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$437 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.42B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...